Skip to main content

Table 2 Haemodynamic variables at baseline

From: Influence of changes in ventricular systolic function and loading conditions on pulse contour analysis-derived femoral dP/dtmax

Haemodynamic variable

DBT (n = 17)a

NE (n = 29)a

VE/PLR (n = 24)a

All interventions (n = 70)a

Femoral dP/dtmax (mmHg s−1)

1049 ± 347

1319 ± 371

1162 ± 336

1199 ± 365

HR (beats min−1)

89 ± 14

92 ± 18

90 ± 15

90 (74–104)

SAP (mmHg)

117 ± 17

137 ± 25

123 ± 14

127 ± 21

MAP (mmHg)

75 ± 7

84 ± 16

78 (75–84)

78 (70–86)

PP (mmHg)

66 ± 17

80 ± 18

70 ± 11

73 ± 17

CVP (mmHg)

9 ± 4

9 (8–12)

11 ± 4

9 (8-12)

GEDVi (mL m−2)

749 ± 120

773 (684–878)

773 ± 146

750 (671–846)

CI (L min−1 m−2)

2.7 ± 0.6

3.1 ± 1.2

3 (2.5–3.5)

3 (2.2–3.4)

SVI (mL m−2)

31 ± 9

35 ± 14

32 (24–45)

32 (25–44)

CFI (min−1)

3.9 ± 1.2

4.3 ± 1.6

4.4 ± 1.7

4.2 ± 1.6

LVEF (%)

43 ± 11

57 (42–61)

54 ± 17

50 ± 14

Ea (mmHg ml−1)

2 ± 0.5

2 (1.3–2.4)

1.9 (1.4–2.2)

1.9 (1.4–2.3)

TAC (ml mmHg−1)

0.9 ± 0.3

0.8 (0.6–1.2)

0.8 (0.8–1.1)

0.8 (0.7–1.1)

SVRi (dynes s cm−5 m−2)

1774 (1657–2379)

2241 ± 1078

1739 (1575–2172)b

1775 (1627–2404)b

  1. Data are presented as mean ± SD or median (25th–75th%)
  2. NE norepinephrine, VE/PLR volume expansion/passive leg raising, DBT dobutamine, HR heart rate, SAP systolic arterial pressure, MAP mean arterial pressure, PP pulse pressure, CVP central venous pressure, GEDVi global end-diastolic volume index, CI cardiac index, SVI stroke volume index, CFI cardiac function index, LVEF left ventricle ejection fraction, Ea effective arterial elastance, TAC total arterial compliance, SVRi systemic vascular resistance index
  3. an value refers to cases